Acurx Pharmaceuticals Receives FDA Conditional Acceptance
ACXP•FDA conditional acceptance and trademark allowance
Aug. 17 (Reuters) - Acurx Pharmaceuticals Inc. ACXP.O:
- Acurx Pharmaceuticals receives FDA conditional acceptance and USPTO trademark allowance for the company's brand name for ibezapolstat.
Related News
Axe Compute and Duos Technologies enter into agreements for 55 MW of new AI data center capacity across multiple U.S. locations
DUOT•
Tomi Secures Critical Ireland Market Approval, Strengthening Steramist's Position Across the European Union
TOMZ•
